Nidhi Chauhan, MD, DM

The authors present a case of trichotillomania in a patient who was managed via telepsychiatry-based habit reversal therapy during the COVID-19 pandemic.

A young man with maladaptive daydreaming was treated with fluvoxamine and cognitive-behavioral therapy.

This study examined if early response to SSRIs can reliably indicate future response to the same drug and compared 2 medications frequently used to treat OCD: sertraline and fluvoxamine.